Data from the Phase II trial shows increase in hair count in 11 out of 14 (79%) evaluable subjects at 24 weeks
ICX-TRC - Hair regeneration
ICX-TRC consists of a suspension of autologous dermal papilla (DP) cells. These cells are able to
stimulate the generation of new hairs when injected into the scalp in close proximity to the epithelial
cells which generate the hair. The purpose of the ongoing Phase II study being conducted by Dr
Bessam Farjo in Manchester is to optimise the delivery of the DP cells.
In this study, hair counts are obtained by shaving and photographing a small section of scalp,
injecting it and then applying a specialised image analysis system to provide a total hair count. Two
sub-groups were each injected with autologous DP cells using different delivery techniques. The first
group focussed on delivery of the hair inductive DP cells, and in the second group resident hair
producing (epithelial) cells were also stimulated at the time of delivery.
At 24 weeks the results are as follows:
• Of the five subjects who received DP cells with no pre-stimulation of the scalp three (60%)
showed an increase in hair counts
• Of the nine subjects who received DP cells with pre-stimulation of the scalp eight (89%)
showed an increase in hair counts
• Two subjects were not evaluable at this time-point
At the end of Q1 next year when the trial has concluded, photographic data will be analysed from a
much larger area of treated scalp on all subjects at 12 months. Currently three subjects have been
lost to follow up.
We are continuing to explore partnering opportunities to continue the next clinical phase of
development of ICX-TRC. Bosley, the largest chain of hair transplant clinics in the US, has an option
to negotiate distribution rights to this product.
That was really worth the wait - No bloody pictures - our Baccy is doing better.Great job Baccy!
» ICX-TRC - hair regeneration
»
» Data from the Phase II trial shows increase in hair count in 11 out of 14
» (79%) evaluable subjects at 24 weeks
»
» ICX-TRC - Hair regeneration
» ICX-TRC consists of a suspension of autologous dermal papilla (DP) cells.
» These cells are able to
» stimulate the generation of new hairs when injected into the scalp in
» close proximity to the epithelial
» cells which generate the hair. The purpose of the ongoing Phase II study
» being conducted by Dr
» Bessam Farjo in Manchester is to optimise the delivery of the DP cells.
» In this study, hair counts are obtained by shaving and photographing a
» small section of scalp,
» injecting it and then applying a specialised image analysis system to
» provide a total hair count. Two
» sub-groups were each injected with autologous DP cells using different
» delivery techniques. The first
» group focussed on delivery of the hair inductive DP cells, and in the
» second group resident hair
» producing (epithelial) cells were also stimulated at the time of
» delivery.
» At 24 weeks the results are as follows:
» • Of the five subjects who received DP cells with no pre-stimulation of
» the scalp three (60%)
» showed an increase in hair counts
» • Of the nine subjects who received DP cells with pre-stimulation of the
» scalp eight (89%)
» showed an increase in hair counts
» • Two subjects were not evaluable at this time-point
» At the end of Q1 next year when the trial has concluded, photographic data
» will be analysed from a
» much larger area of treated scalp on all subjects at 12 months. Currently
» three subjects have been
» lost to follow up.
» We are continuing to explore partnering opportunities to continue the next
» clinical phase of
» development of ICX-TRC. Bosley, the largest chain of hair transplant
» clinics in the US, has an option
» to negotiate distribution rights to this product.
»
»
» That was really worth the wait - No bloody pictures - our Baccy is doing
» better.Great job Baccy!
This means… a big nothing!! This could be the report of the last year, the info are the same, no new news or discovers… The same percentage %% without ANY REFERENCES… so 79% of what?? How many hairs means that… 7 hairs?? 70 hairs?? I think that 7 will be a good number for them, so in the next Q3 of the 2017 the will have more data to analize and release the PHASE 2(3) results…
Yes, i think baccy is doing a better work
They seem to keep losing trialists to follow-up. At one point they were advertising for trialists in local newspapers DESPITE having both Baldie42 and myself on their books ready for prescreening.
The irony is that if they would have called me in for trials, I would have stuck with it. I wouldn’t have been lost to follow-up.
Whats the problem? they never promised pictures until the endof phase II.
Losing 3 patients to follow up is not that big a deal. For example they could have died, left the country or simply unavailable on the evaluation day.
Of course they could have left the program because results weren’t as expected etc.
People act as if ICX owe them something, which is ridiculous.
If they don’t provide pics and more detailed results by the end of phase II, then theres reason to be pissed off.
» Look at one of the last page of the document, they have a slide that are
» talking about 2 ways to use ICX-TRC…
»
» - In vitro ( proto hair )
» - In vivo
»
» It looks like they are trying or will try protohair…
»
» What’s your thought???
» We are continuing to explore partnering opportunities to continue the next
» clinical phase of
» development of ICX-TRC. Bosley, the largest chain of hair transplant
» clinics in the US, has an option
» to negotiate distribution rights to this product.
It almost seems like ICX has toned down the partnership talks. Last time, they were talking about how it was necessary to partner w/ someone else or else there would be no phase III; here that tone of necessity isn’t there. Either they just didn’t feel like repeating themselves, or they don’t feel they HAVE to partner w/ another group to do phase III.
» » We are continuing to explore partnering opportunities to continue the
» next
» » clinical phase of
» » development of ICX-TRC. Bosley, the largest chain of hair transplant
» » clinics in the US, has an option
» » to negotiate distribution rights to this product.
»
»
» It almost seems like ICX has toned down the partnership talks. Last time,
» they were talking about how it was necessary to partner w/ someone else or
» else there would be no phase III; here that tone of necessity isn’t there.
» Either they just didn’t feel like repeating themselves, or they don’t feel
» they HAVE to partner w/ another group to do phase III.
Wow, talk about reading too much into things.
Bosley has first dibs, if they don’t want it after a certain amount of time they are open to offers, so to speak.
Very disappointing that there is no mention of ICX-TRC . It doesn’t look like there is much motivation when it comes to their ICX-TRC product. That can’t possibly be a good sign. I hope that I am wrong
» This means… a big nothing!! This could be the report of the last year,
» the info are the same, no new news or discovers… The same percentage %%
» without ANY REFERENCES… so 79% of what?? How many hairs means that… 7
» hairs?? 70 hairs?? I think that 7 will be a good number for them, so in the
» next Q3 of the 2017 the will have more data to analize and release the
» PHASE 2(3) results…
» Yes, i think baccy is doing a better work
» I/We wait a half year of a new update and than this sh****t!
Exactly. I said this before, and I’ll say it again. I think their technology has some merit, BUT I think their management team is incompetent.
» » I/We wait a half year of a new update and than this sh****t!
» Exactly. I said this before, and I’ll say it again. I think their
» technology has some merit, BUT I think their management team is
» incompetent.
»
»
» .
What can we do…,look at follica or Baccy:-)
This is an advertising site for paid
advertisers to showcase successful hair restoration results only. It is not the
mandate of this site to engage in the discussion of failed, unsuccessful
procedures, lawsuits, litigations, refunds or complaint cases. Surgical hair
restoration procedures carry risks. Please do thorough research, consult your
own physician and investigate a doctor's background carefully before making a
decision. By proceeding to use our site, you agree to abide by our Terms of Use & Privacy Policy at http://hairsite.com/terms-of-use/ where you can also find a list of HairSite's sponsoring physicians.
. It doesn’t look like there is much motivation when it comes to their ICX-TRC product. That can’t possibly be a good sign. I hope that I am wrong